Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!
EMD-50835
N-VelcroVax HBcAg in complex with SUMO-gp1 (T=4 VLP)
EMD-50835
Single-particle3.5 Å
Deposition: 30/06/2024Map released: 26/02/2025
Last modified: 05/03/2025
Sample Organism:
synthetic construct
Sample: T=4 virus-like particle of N-VelcroVax HBcAg in complex with SUMO-tagged gp1 from JUNV
Deposition Authors: Fatema K
,
Snowden JS ,
Watson A ,
Sherry L ,
Ranson NA ,
Stonehouse NJ ,
Rowlands DJ
Sample: T=4 virus-like particle of N-VelcroVax HBcAg in complex with SUMO-tagged gp1 from JUNV
Deposition Authors: Fatema K
,
Snowden JS ,
Watson A ,
Sherry L ,
Ranson NA ,
Stonehouse NJ ,
Rowlands DJ
A VLP vaccine platform comprising the core protein of hepatitis B virus with N-terminal antigen capture.
Fatema K ,
Snowden JS ,
Watson A ,
Sherry L ,
Ranson NA ,
Stonehouse NJ ,
Rowlands DJ
(2025) Int J Biol Macromol , 305 , 141152 - 141152
,
Snowden JS ,
Watson A ,
Sherry L ,
Ranson NA ,
Stonehouse NJ ,
Rowlands DJ
(2025) Int J Biol Macromol , 305 , 141152 - 141152
Grant Support:
- Wellcome Trust: 102174/B/13/Z (United Kingdom)
- Wellcome Trust: 108466/Z/15/Z (United Kingdom)